Cell-based drug delivery harnesses inflammatory and autoimmune responses in neurodegeneration.

Pozo, David2023-02-092023-02-092021-03-08http://hdl.handle.net/10668/17327enAnimalsAutoimmunityDrug Delivery SystemsEncephalomyelitis, Autoimmune, ExperimentalHumansIndolesMaleimidesMesenchymal Stem CellsMiceMultiple SclerosisTransplantation, HeterologousTreatment OutcomeCell-based drug delivery harnesses inflammatory and autoimmune responses in neurodegeneration.research article33683375open access10.1007/s00109-021-02059-11432-1440PMC7938677https://link.springer.com/content/pdf/10.1007/s00109-021-02059-1.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938677/pdf